THE PREVALENCE ESTIMATES OF MACULAR TELANGIECTASIA TYPE 2: The Melbourne Collaborative Cohort Study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Retina

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/IAE.0b013e3181bd2c71PMID 19952995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-mydriatic Digital Macular Photography: How Good is the Second Eye Photograph?

  2009cited by this paper
• Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia.

  2008cited by this paper
• The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.

  2008cited by this paper
• Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia.

  2008cited by this paper
• Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia.

  2008cited by this paper
• Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia.

  2007cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis in monozygotic twins

  2007cited by this paper
• Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis

  2007cited by this paper
• Idiopathic Macular Telangiectasia

  2006cited by this paper
• Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography.

  2006cited by this paper
• Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis.

  2006cited by this paper
• Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies

  2005cited by this paper
• Group 2A idiopathic juxtafoveolar retinal telangiectasia in monozygotic twins.

  2005cited by this paper
• A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy.

  2000cited by this paper
• An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

  1995cited by this paper
• An international classification and grading system for age-related maculopathy and age-related macular degeneration

  1995cited by this paper
• Distribution of fundus autofluorescence with a scanning laser ophthalmoscope.

  1995cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis

  1993cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

  1993cited by this paper
• The Wisconsin age-related maculopathy grading system.

  1991cited by this paper
• Paramacular telangiectasis.

  1986cited by this paper
• Parafoveal telangiectasis and diabetic retinopathy.

  1986cited by this paper
• Idiopathic juxtafoveolar retinal telangiectasis.

  1982cited by this paper

• Macular Telangiectasia Type 2: The Role of Optical Coherence Tomography and Management Options.

  2026cites this paper
• Results from a Phase I Extension Study of Ciliary Neurotrophic Factor in Patients with Macular Telangiectasia Type 2.

  2025cites this paper
• Clinical histopathology and pathogenesis of macular telangiectasia type 2.

  2025cites this paper
• Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2.

  2025cites this paper
• Neuroprotective properties of ciliary neurotrophic factor in the retina for the treatment of macular telangiectasia type 2.

  2025cites this paper
• Genetic Background of Macular Telangiectasia Type 2

  2025cites this paper
• Plasmid Gene Therapy for Monogenic Disorders: Challenges and Perspectives

  2025cites this paper
• Ethnic comparison of MacTel over 5 years follow up.

  2025cites this paper
• PLASMA RICH IN GROWTH FACTORS MEMBRANE IN THE TREATMENT OF MACULAR HOLES ASSOCIATED WITH MACTEL TYPE 2.

  2024cites this paper
• Macular telangiectasia type 2 in a patient with Down syndrome: A possible association

  2024cites this paper
• High-Resolution Imaging in Macular Telangiectasia Type 2: Case Series and Literature Review

  2024influential citation
• Maladie de Coats et télangiectasies rétiniennes

  2024cites this paper
• Self-Supervised Learning for Improved Optical Coherence Tomography Detection of Macular Telangiectasia Type 2.

  2024cites this paper
• iPSC–derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function

  2023cites this paper
• Unraveling the mysteries of macular telangiectasia 2: the intersection of philanthropy, multimodal imaging and molecular genetics. The 2022 founders lecture of the pan American vitreoretinal society

  2023cites this paper
• Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients

  2023cites this paper
• Baseline demographic, clinical and multimodal imaging features of young patients with type 2 macular telangiectasia

  2023cites this paper
• Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients

  2023cites this paper
• Characterization of the Retinal Phenotype Using Multimodal Imaging in Novel Compound Heterozygote Variants of CYP2U1

  2023cites this paper
• Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN1

  2022cites this paper
• Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2

  2022cites this paper
• Macular Telangiectasia Type 2: Case Report and Clinical Review

  2022cites this paper
• Macular Telangiectasia Type 2: A Comprehensive Review

  2022cites this paper
• Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease

  2021cites this paper
• Prevalence and Severity of Diabetic Retinopathy in Patients with Macular Telangiectasia type 2.

  2021cites this paper
• Feasibility study to improve deep learning in OCT diagnosis of rare retinal diseases with few-shot classification

  2021cites this paper
• Sphingolipids as critical players in retinal physiology and pathology.

  2021cites this paper
• Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression

  2020cites this paper
• Subretinal Neovascularization Associated with Idiopathic Juxtafoveal Telangiectasia

  2020cites this paper
• Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease

  2020cites this paper
• Sphingolipids as critical players in retinal physiology and pathology

  2020cites this paper
• Idiopathic Macular Telangiectasia

  2020cites this paper
• Twenty-Year Incidence of Macular Telangiectasia Type 2 and Associated Systemic Comorbidities in Olmsted County, Minnesota.

  2020cites this paper
• Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.

  2019cites this paper
• Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.

  2019cites this paper
• The Diagnosis and Management of Macular Telangiectasia.

  2019cites this paper
• Retinal Pathologic Features on OCT among Eyes of Older Adults Judged Healthy by Color Fundus Photography.

  2019cites this paper
• Varied optical coherence tomography angiography patterns at different stages of macular telangiectasia type 2 – analysis of 15 cases

  2019cites this paper
• No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case–control study and retrospective cohort study

  2018cites this paper
• Optic Coherence Angiography Findings in Type-2 Macular Telangiectasia

  2017cites this paper
• [Inefficacy of aflibercept in the treatment of idiopathic macular telangiectasia type 2 without neovascularization].

  2017cites this paper
• CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY

  2017cites this paper
• Genome-wide analyses identify common variants associated with macular telangiectasia type 2

  2017cites this paper
• Inefficacité de l’aflibercept dans le traitement des télangiectasies maculaires idiopathiques de type 2 sans néovascularisation

  2017cites this paper
• Optical Coherence Tomography Angiography Findings in Type-2 Macular Telangiectasia

  2017cites this paper
• Vascular Malformations of the Retina and Posterior Segment of the Eye

  2016cites this paper
• The Use of SWEPT SOURCE OCT Angio in Diagnosis and Staging of Type 2 Macular Telangictasia (MacTel 2)

  2016cites this paper
• Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report)

  2016cites this paper
• Salient features and management options of macular telangiectasia type 2: a review and update

  2016cites this paper
• Maladie de Coats et télangiectasies

  2016cites this paper
• Apports du ranibizumab dans le traitement des télangiectasies maculaires de type 2 non néovascularisées

  2016cites this paper
• [Ranibizumab as a treatment for type 2 non-proliferative macular telangiectasia].

  2016cites this paper
• Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2.

  2015cites this paper
• SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2

  2015cites this paper
• Demographic Features of Idiopathic Macular Telangiectasia in Korean Patients

  2015cites this paper
• Clinical Studies into the Causes of Idiopathic Macular Telangiectasia Type 2: Sleep Apnoea and Macular Telangiectasia: The SAMTel Project

  2015cites this paper
• Swept-source OCT angiography of macular telangiectasia type 2.

  2014cites this paper
• CHARACTERISTICS OF CYSTOID SPACES IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGES

  2014cites this paper
• Macular telangiectasia type 2.

  2013cites this paper
• PREVALENCE AND PROGRESSION OF PIGMENT CLUMPING ASSOCIATED WITH IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2

  2013cites this paper
• Occlusive idiopathic juxtafoveolar retinal telangiectasis type 4.

  2013cites this paper
• Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).

  2013cites this paper
• Chapter 55 – Macular Telangiectasia

  2013cites this paper
• THE PREVALENCE AND RISK FACTORS OF EPIRETINAL MEMBRANES: The Melbourne Collaborative Cohort Study

  2013cites this paper
• Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3

  2013cites this paper
• Pars plana vitrectomy with internal limiting membrane removal in type 2 idiopathic macular telangiectasia.

  2013cites this paper
• Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2

  2012cites this paper
• How Prevalent is Macular Telangiectasia Type 2?

  2012cites this paper
• TREATMENT OF NONNEOVASCULAR IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 WITH INTRAVITREAL RANIBIZUMAB: Results of a Phase II Clinical Trial

  2012cites this paper
• The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations

  2012cites this paper
• The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.

  2010cites this paper
• Analysis of candidate genes for macular telangiectasia type 2

  2010cites this paper
• Idiopathic Juxtafoveolar Retinal Telangiectasis: A Current Review

  2010cites this paper
• VISIBLE AND EXUDATIVE IDIOPATHIC JUXTAFOVEOLAR RETINAL TELANGIECTASIS ( “ Idiopathic Macular Telangiectasia Type 1 ” or “ Aneurysmal Telangiectasia ” )

  2010cites this paper
• Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2

  2010cites this paper